We investigated whether the nitric oxide (NO) synthase inhibitor �-nitro-L-arginine methyl ester (L NAME) affects the cerebrovascular changes occurring in seizures induced by kainic acid (KA) in awake, sponta neously breathing rats. Blood flow and tissue P02 and Pco2 were continuously and simultaneously measured by mass spectrometry from a cannula chronically implanted into the dorsal hippocampus. L-NAME (20 mg/kg; n = 8) or saline (n = 9) was administered i.p. 30 min prior to i.p. KA (10 mg/kg) injection. L-NAME significantly de creased hippocampal blood flow and P02 and increased mean arterial blood pressure (MABP). In L-NAME treated rats, seizure activity occurred about 10 min sooner than in control rats, and status epilepticus was inevitably followed by a flat electroencephalogram and Nitric oxide (NO) is a diffusible molecule that is identical with or derived from one of the endothe lium-derived relaxing factors. In neurons and the endothelium, NO is produced from the enzymatic conversion of L-arginine to L-citrulline by a Ca 2 +calmodulin-dependent NO synthase (NOS) requir ing NADPH and O2 (Palmer et aI., 1988), This re action can be inhibited by several analogs of L-ar ginine including � -nitro-L-arginine methyl ester (L-NAME) (Rees et aI., 1990). In recent years, a growing body of evidence has suggested that NO contributes to the regulation of blood vessel tone and acts as a peripheral and cen tral neuronal messenger (Garthwaite et aI., 1988).
sudden death. In contrast, control rats survived KA induced seizures. Hippocampal blood flow was signifi cantly less elevated during the seizures in L-NAME treated rats than in control rats (maximal levels, 170 and 450%, respectively, of baseline values), though MABP remained significantly higher. Hippocampal P02 was sig nificantly decreased at all times after KA injection in L-NAME-treated rats, whereas it remained at or above normoxic levels in control rats. The present results show that L-NAME markedly attenuates the hippocampal blood flow and tissue P02 changes in response to en hanced metabolic activity due to limbic seizures and sug gest that NO is of major importance in cerebral blood flow control during KA-induced seizures. Key Words: Ni tric oxide-Seizures-Kainate-CBF-L-NAME.
NOS immunoreactivity has been shown in endothe lial cells of blood vessels and in discrete popUlations of neurons in the CNS, and a dense network of NOS-immunoreactive nerve fibers has been re vealed in the adventitia of cerebral blood vessels (Bredt et aI., 1990; Nozaki et aI., 1993) . Previous studies have suggested a double-edged role for NO, both beneficial and deleterious (Schmidt et aI., 1992 ). On the one hand, NO has been proposed as a new chemical mediator coupling cerebral blood flow (CBF) to neuronal activity. It is known that NO exerts a tonic vasorelaxant influence on both the cerebral and the peripheral circulations (Tanaka et aI., 1991; Kozniewska et aI., 1992; Macrae et aI., 1993) , and most authors have found that NO plays a role in CBF control (Iadecola, 1992; Kozniewska et aI., 1992; Wang et aI., 1992; Dirnagl et aI., 1993; Pelligrino et aI., 1993) , but its role during hypercap nia and activation remains controversial (Sokoloff et aI., 1992) . Similarly, there is no agreement con cerning the role of NO in the cerebral hyperemia due to bicuculline-induced seizures (Beckman et aI., 1993; Goadsby and Hoskin, 1993) , On the other hand, NO has also been proposed to play a major role in glutamate toxicity (Dawson et aI., 1991) , al though discrepant results have been found concern ing the effects of NOS inhibitors in ischemia and in epileptic seizures. Some authors have shown that NOS inhibitors reduce the volume of the infarct (Nowicki et aI., 1991; Buisson et aI., 1992; Nishikawa et aI., 1993) , whereas others found no protective role of NOS inhibitors in either focal ischemia (Dawson et aI., 1992; Yamamoto et aI., 1992) or global ischemia (Moncada et aI., 1992; Weissman et ai., 1992) . Similarly, in seizure induced neuronal degeneration, which bears simi larities to ischemia-induced cell injury, NO has been shown to have both deleterious effects (De Sarro et aI., 1991; Mollace et ai., 1991; Bagetta et aI., 1992) and beneficial effects (Haberny et aI., 1992; Starr and Starr, 1993) .
In the present work, we studied a model of limbic seizures induced in rats by a glutamate analog, kainic acid (KA). Systemic administration of KA induces typical limbic seizures whose behavioral, electroencephalographic, thermal, systemic, meta bolic, and cerebrovascular characteristics in awake rats have been extensively described previously (Ben Ari et aI., 1981; Lothman and Collins, 1981; Pinard et aI., 1984 Pinard et aI., , 1987 The aim of the present study was to determine the influence of a NOS blocker, L-NAME, on the cere brovascular, thermal, systemic, electrographic, and behavioral effects of KA-induced seizures and thus to assess whether NO is mostly beneficial or mostly deleterious in prolonged limbic seizures.
METHODS

Measurement of cerebral blood flow and tissue partial pressures of oxygen and carbon dioxide by mass spectrometry
The technique we used has been described and vali dated in previous papers (Seylaz and Pinard, 1978; Seylaz et aI., 1983) . Minute quantities of physiological tissue gases are withdrawn via a gas-sampling cannula (0.7-mm outer diameter) implanted chronically and stereotaxically into the brain. The gases are aspirated by the high vac uum (10-9 torr) of the mass spectrometer (Riber QMM 17) and introduced into the analysis chamber, where the molecules are ionized, accelerated, and separated accord ing to their molecular weight. This method allows quan titative monitoring of local tissue P02 and Pe02 and blood flow with the same cannula over periods of several hours. Vol. 14, No.4, 1994 Tissue P02 and Peo2 measurements are contil}uous, whereas blood flow measurements are made sequentially about every 5 min.
Local blood flow is calculated from the clearance of a tracer gas, helium, which is periodically added to the air inhaled by the animal and replaces the same percentage of N2• When the partial pressure of helium, as measured by mass spectrometry, reaches a plateau, helium is removed from the inhaled air. Its clearance from the brain enables CBF to be calculated from the helium monoexponential clearance curve according to the Fick principle:
where A is the tissue-blood partition coefficient, which is 1 in the case of helium.
The local blood flow is determined from the helium clearance curve displayed on-line from inputs obtained every 0.5 s over a period of 30-40 s by a computer (lPC 386). Blood flow values are expressed as ml . 100 g-l . min-I.
Protocol
All experimental procedures were carried out in strict accordance with National Institute of Health Guidelines. Experiments were performed under permit no. 727 from the French Ministry of Industry and Research.
The studies were performed in 17 male Wi star rats (280-320 g). They had access to food and water ad libitum and were housed in individual cages.
Two weeks before the experiment, the rats were anes thetized with chloral hydrate (300 mg/kg, i.p.) and placed in a David Kopf stereotaxic apparatus. A gas-sampling cannula was stereotaxically implanted into the dorsal hip pocampus of each rat. The coordinates determined from Paxinos and Watson's atlas were as follows: interaural axis, 5.7 mm; lateral, 2 mm; and vertical, 3 mm from the dura mater surface. Concomitantly, three cortical screws were placed in contact with the dura mater to record the electrocorticogram (ECoG) on a polygraph (ECEM) at 15 mmls. The cannula and the screws were fixed to the skull with dental cement and protected with an epoxy cover.
Two days before the experiment, under chloral hydrate anesthesia (300 mg/kg, i.p), a thin-walled catheter filled with polyvinyl pyrrolidone and heparin was inserted into the femoral artery and channeled subcutaneously to exit at the neck. On the day of the experiment, the unanes thetized, spontaneously breathing rat was placed in a hammock where it could freely move its head and limbs and was allowed to rest for about 2 h. The rectal temper ature (RT) was measured and a heating lamp was used to try to maintain RT at 37-38°C. The arterial catheter was connected to a pressure transducer (Statham P23Db) to continuously monitor arterial blood pressure. Samples of arterial blood were withdrawn every 30 min to measure Pao2, Paeo2, and pH with a Coming 178 pH-blood gas analyser; and glycemia was measured with a reflective photometer (Reflolux). A mask was placed over the rat's muzzle for inhalation of the gas mixture (either 25% ox ygen and 75% nitrogen or 25% oxygen, 65% nitrogen, and 10% helium). The gas-sampling cannula was connected to a mass spectrometer (Riber QMMI7) for simultaneous measurement of hippocampal tissue Po2, Peo2, and blood flow. Arterial blood pressure and the cerebrovascular variables were displayed on a polygraph recorder (Gould). The electrographic activity was continuously monitored and behavior was noted.
When all variables were stable, the rats were given either saline (n = 9) or L-NAME (n = 8) at 20 mg/kg.
Thirty minutes later, all rats were given KA (10 mg/kg). Saline-treated rats were the control group. All drugs were from Sigma Chemical Company. They were dissolved in normal saline (pH, 7.4) and injected i.p. All variables were monitored throughout the experi ment, i.e., in basal conditions, under L-NAME or saline treatment and up to 240 min after KA injection whenever possible. All measurements were averaged over IS-min periods over the whole experiment. Tissue P02 and Pe02 were expressed as percentages of control values. Cere bral vascular resistance (CYR) was calculated by dividing mean arterial blood pressure (MABP) by blood flow. The main electrographic features were evaluated by inspec tion of the records. Quantitative comparisons of the epi leptic discharges were carried out in several cases and every 20-s period of the recording was classified as one of the following: normal electroencephalogram (EEG), EEG with regular or irregular spikes, or electrographic seizures with or without motor events. The intensity of seizures was also assessed using some key behavioral events, in cluding wet-dog shakes (WDS), myoclonus of the facial muscles, head nodding, rearing and tremor of the fore paws, and full motor convulsion.
Statistical analysis
In each group, analysis of variance (ANOYA) followed by Dunnett's test was used to compare basal values with subsequent values (i.e., under saline or L-NAME alone, then under KA). A second series of intergroup compari sons was made between basal values, between values un der L-NAME or saline alone, and between values under KA. This series was performed by t test or Mann Whitney nonparametric test when the variances were too different; p < 0.05 was considered significant. Results are expressed as means ± SD.
RESULTS
All rats were in a similar physiological state be fore any drug injection. Basal values of physiolog ical variables are reported in Tables I and 2 .
Effects of L-NAME alone L-NAME induced a significant increase in MABP without changing any other systemic parameter 42.4 ± 3.7 39.9 ± 6.0 38.7 ± 3.5
Glycemia (mg/dl) 116.7 ± 7.3 124.7 ± 18.3 108.4 ± 9.9
Shown are arterial pH, blood gases, and glycemia values at baseline and 30 min after L-NAME (20 mg/kg) injection. All variables are means ± SD.
There were no significant differences between groups.
( Tables I and 2 ). Temperature was not significantly modified. No abnormality was observed in ECoG.
L-NAME induced a significant decrease in hippo campal blood flow associated with a significant de crease in tissue Po2, while Peo2 did not significantly change. CVR was increased to approximately twice its basal value.
Effects of KA
ECoG and behavioral activity, In all rats, KA in duced convulsive motor seizures associated with status epilepticus, i.e., uninterrupted paroxysmal electrical activity.
Immediately after KA injection, the rats were still. Within 10 min, they began to hyperventilate.
Isolated spike activities or bursts of low-amplitude spikes occurred sooner in L-NAME-treated rats (�5-20 min after the KA injection) than in control rats (�10-25 min after the KA injection; Fig. lA ).
Spikes were not systematically associated with any behavioral change.
Approximately 20-45 min after KA injection, the rats displayed WDS (Fig. IB) . In both groups of rats, WDS occurred frequently for >30 min and were rapidly followed by masticatory movements, myoclonic jerks, and salivation. Typical electro graphic recordings in L-NAME-treated and control rats are presented in Fig. 2 . High-amplitude, high frequency spike discharges appeared �45 min after KA injection in L-NAME-treated rats and were then observed constantly (150-600 spikes/min) until a breakdown in the electrical activity occurred, . ) with comparisons of saline-treated rats and L-NAME-treated rats. Note that seizure activity occurred sooner in L-NAME-treated rats than in control rats.
leading to the rat's death within a few minutes. Ap proximately 20 min after the beginning of paroxys mal electrical activity, L-NAME-treated rats exhib ited full motor convulsions whose intensity re mained maximal until a flat ECoG was seen.
Similar electrical and behavioral events occurred in control rats with a lag of �20 min compared with L-NAME-treated rats. after the injection. The absolute values of, the MABP were significantly higher in L-NAME treated rats than in control rats at all times after the KA injection .
Pao2 was not significantly changed, while Paeo2 decreased significantly and prog r essively (Fig. 3A) ,
indicating hyperventilation. The decrease in Paeo2 was significantly greater in L-NAME-treated rats during the seizures. Arterial pH increased signifi cantly during the seizures in control rats (probably because of the hyperventilation), but it remained unchanged for 60 min after KA injection in L-NAME-treated rats before falling significantly, indicating severe metabolic acidosis (Fig. 3B) In pilot experiments (n = 6) designed to deter mine the possible role of late hypoglycemia in the j death of L-NAME-treated rats, the maintenance of glycemia within the normal range in L-NAME treated rats did not prevent the rats from dying dur ing seizures (at a mean time of 95 min), indicating that hypoglycemia was not the lethal factor in L-NAME-treated rats.
All rats developed hypothermia during the first 45 min after KA injection (35.6 ± 1. 1°C in control rats and 35.5 ± 0.9°C in L-NAME-treated rats at 45 min). However, although temperature returned to its basal level within the following hour in control rats, it decreased to 34.0 ± 1.4°C in L-NAME treated rats, although they were heated by a lamp.
Cerebrovascular variables. Blood flow started to increase significantly in the hippocampus between 30 and 45 min after the KA injection in both groups of rats (Fig. 4) . In control rats, blood flow reached a maximum value �90 min after KA injection; flow then remained at this level for � 1 h. In contrast, blood flow returned to its basal value in L-NAME treated rats and remained unchanged despite per sistent status epilepticus and convulsive motor sei zures.
Concomitantly, a significant difference in tissue P02 was measured between the two groups ( Fig. 5 ).
P02 tended to increase in control rats, whereas it was significantly lowered in L-NAME-treated rats, Comparison of arterial partial pressures of carbon dioxide (A) and arterial pH (B) at various times after KA in jection in rats given L-NAME (n = 8) or the same volume of saline (n = 9) 30 min before KA. L-NAME-treated rats did not survive the seizures; thus, n = 6 at 90 min. KA induced a significant decrease in Paco2 in both groups, probably due to hyperventilation. The decrease in Paco2 was significantly enhanced in L-NAME-treated rats during seizures. A signifi cant alkalosis was found in control rats during seizures, whereas pH became acid in L-NAME-treated rats during par oxysmal activation; *, p < 0.05 compared with baseline value; black triangle, p < 0.05 compared with saline group.
in control rats during the whole period following KA injection. L-NAME alone approximately dou bled the CVR, and following KA injection, a large decrease in CVR was observed; this decrease, how ever, was largely reversed from 60 min onward. At all times during the experiment, CVR was signifi cantly higher in L-NAME-treated rats than in con trol rats.
In each L-NAME-treated rat, the ECoG flatten ing that occurred before death was associated with a progressive decrease in blood flow and tissue P02 down to 0, concomitant with a massive increase in tissue Peo2 to 300% of baseline (not shown). These Either saline or L-NAME was given 30 min before KA. Control rats (n = 9) exhibited a high and sustained increase in CBF throughout the seizures and fully recovered. In contrast, L-NAME-treated rats (n = 8) exhibited a small increase in CBF (significant only at the beginning of seizure activity) despite uninter rupted spike activity-Le., status epilepticus. L-NAME treated rats did not survive the seizures; thus, n = 6 at 90 min and n = 3 at 105 min; *, p < 0.05 compared with baseline value (time, -30 min); black triangle, p < 0.05 compared with saline group. Fig. 4 . See Fig. 4 for numbers of rats. L-NAME alone induced a de crease in tissue Po2. During seizures, P02 tended to increase in control rats, whereas it was significantly lowered in L-NAME-treated rats; " p < 0.05 compared with baseline value (time, -30 min); black triangle, p < 0.05 compared with saline group. cerebrovascular events always preceded any sys temic event. In control rats, blood flow remained significantly elevated until at least 240 min after KA injection, along with high P02 and low Peo2 levels, though all variables tended to return to basal val ues.
DISCUSSION
The major finding of the present study is that L-NAME greatly attenuated the massive and sus- Comparison of CVR values before and at various times after KA injection in rats given L-NAME or the same volume of saline 30 min before KA. See Fig. 4 for number of rats. L-NAME alone induced an increase in CVR. After KA injection, CVR progressively decreased in control rats, whereas CVR started decreasing in L-NAME-treated rats but increased thereafter. CVR was significantly higher in L-NAME-treated rats than in control rats over the whole ex periment; " p < 0.05 compared with baseline value; black triangle, p < 0.05, compared with saline group. Vol. 14, No.4, 1994 tained hippocampal hyperemia that occurred d,uring seizures induced by kainic acid in awake, sponta neously breathing rats. It is also interesting to note that the L-NAME-treated rats did not recover from epileptic seizures, in contrast with the control rats.
The present results indicate that L-NAME inter feres not only with the coupling mechanism of local blood flow to seizure-related enhanced metabolic activity, but also with vital reactions in seizures. In addition, the present data confirm that, in control conditions, L-NAME induces a decrease in blood flow in the hippocampus associated with an in crease in arterial blood pressure of the same order of magnitude as previously reported in awake rats (Macrae et a!., 1993).
The choice of L-NAME was dictated by its pre vious characterization as an NO synthesis inhibitor (Rees et a!., 1990). Inhibition of the vascular NOS has been shown both in vitro and in vivo at the dose we used, and its reversibility by L-arginine hydro chloride has been demonstrated. In the present study, the effect of L-NAME on MABP and CBF provided evidence of the efficacy of the vascular NOS blockade. However, the dose of L-NAME used, i.e., a single injection of 20 mg/kg, probably only partially inhibited the brain NOS activity in rats (Maynard et a!., 1993), although a single injec tion of 10 mg/kg was sufficient to block NOS activ ity completely in cats for 4 h (Nishikawa et a!., 1993). Before reaching conclusions about the role of NO in the cerebrovascular reactions under study, some discussion about the effects of L-NAME not attributable to NOS inhibition is needed, since L-NAME has been shown to be a muscarinic antag onist (Buxton et a!., 1993) . However, the seizures induced by KA mostly involve glutamatergic path ways rather than cholinergic pathways, and in the present experiments, the seizure intensity (electro graphic and behavioral events) was not reduced by L-NAME. In addition, it is known that the musca rinic influence on cerebral blood vessels is exerted via NO release from the endothelium, which means that muscarinic inhibition might also indirectly de crease NO release from the vascular wall. L-NAME has also been suggested to have vasoactive effects not only by inhibiting NOS, but also by blocking iron-dependent systems (Peterson et aI., 1992); however, the concentrations required to inhibit such systems significantly are appreciably higher than the effective tissue concentration in our exper iments. We tentatively propose, therefore, that in our experimental conditions, the inhibition of NO synthesis is the major phenomenon responsible for the mismatch between local blood flow and meta bolic activity, suggesting that NO plays a cardinal role in the control of CBF and is of vital importance in seizures. This assumption is further supported by an ongoing study using laser Doppler flowmetry that shows that the inhibition by L-NAME (at the same dose as used here) of the seizure-induced hy peremia in the parietal cortex is completely pre vented by previous administration of 300 mg/kg L-arginine (unpublished observations). With regard to the regulation of CBF in physiological condi tions, these results support the conclusions of other studies that NO has a tonic influence in the normal regulation of cerebrovascular tone and CBF (Tanaka et al., 1991; Sokoloff et al., 1992; Macrae et aI., 1993) . They also show that the administration of L-NAME causes a decrease in local oxygen supply, which parallels the decrease in local blood flow, without enhancement of CO2 production by the tis sue. This finding suggests that L-NAME per se does not affect brain oxidative metabolism and adds some support to the recent results of Macrae et aI. hypothermic effect has also been described in con trol conditions in unanesthetized rats (Macrae et aI., 1993) . This hypothermia could be due to an effect on the hypothalamus since NOS immunoreactivity has been shown in this structure (Vincent and Kimura, 1992) . Such a decrease in temperature should have aff orded some protection to L-NAME-treated rats.
The prevention by L-NAME of cerebral hyper emia during seizures leads to a significant lowering of tissue P02 that may be deleterious to hippocam pal tissue. Both the decrease in temperature and the severe arterial acidosis measured in L-NAME treated rats during motor seizures could alter oxy gen delivery to tissue, but since their effects on the oxygen-hemoglobin dissociation curve are oppo site, their global influence is not likely to be of ma jor importance. That the hippocampal Peo2 tended to decrease in both L-NAME-treated and control rats throughout the seizures may be explained by the hyperventilation, which led to a decrease in ar terial Peo2, which was more marked in L-NAME-treated rats. We hypothesize that the arterial Peo2 had a marked influence on the measured value of tissue Peo2 that integrated local CO2 production, , 1993) . L-NAME was also found to be proconvulsant when injected i.p. with pilocarpine in awake mice (Starr and Starr, 1993) .
It has been proposed that the discrepancies in the findings from various studies could be attributed to the different routes of drug administration. Our re sults offer some support for this explanation since the rats given L-NAME systemically exhibited WDS and status epilepticus before the control rats.
The amplitude and frequency of their epileptic dis charges were similar to those in control rats, but they died during the seizures whereas control rats survived. Some authors have also noted a high mor tality in rats given NOS inhibitors in combination with either seizures (Haberny et aI., 1992; Starr and Starr, 1993) or ischemia (Beckman et aI., 1992; Moncada et aI., 1992) , which suggests that inhibi tion of NO synthesis may exacerbate the deleteri ous consequences of these pathologies. The possi ble involvement of the late hypoglycemia in the J Cereb Blood Flow Metab, Vol. 14, No.4, 1994 mortality may be excluded in the present stu�y, since artificially maintained normoglycemia did not prevent L-NAME-treated rats from dying. Possi bly, however, an action of L-NAME on cerebrovas cular permeability (Prado et aI., 1992) together with increased CVR during seizures induced brain edema, which could have further reduced the mi crocirculation.
In conclusion, taken together the results of the present study, in which L-NAME virtually abol ished the increase in hippocampal blood flow asso ciated with KA-induced seizures and resulted in lo cal tissue hypoxia, suggest that, whatever its origin, NO plays a major role in CBF control. This role is of importance in physiological conditions and ap pears to be vital in limbic seizures, However, it remains to be determined whether insufficient local blood flow and oxygen supply, associated with in creased CVR, are the lethal elements in L-NAME treated rats or whether the blockade of NOS is del eterious because it modifies crucial elements other than the brain circulation during KA-induced limbic seizures.
